Category: Regulatory/FDA

OPDP Enforcement Letter Cites Hospira for Omission of Risk in YouTube Video

Pacira Prevails in Exparel Settlement with FDA

Rocky Political Road Ahead for Pharma Industry

Kaiser Poll: DTC Ads Have High Profile, But Mixed Reviews

FDA Study of DTC Ads Reaches Critical Mass

Senate Bill Would Loop Nurse Practitioners and PAs into Sunshine Reporting

Pacira Files Complaint Calling FDA Marketing Restrictions Unconstitutional

CHC and CCC Launching Regulatory Compliance University for Agencies, Publishers

Amarin Federal Court Decision: FDA Off-Label Marketing Rules Violate the First Amendment By John Kamp